Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Techne Cp Cmn (TECH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 3,796,666
  • Shares Outstanding, K 37,310
  • Annual Sales, $ 499,020 K
  • Annual Income, $ 104,480 K
  • 36-Month Beta 0.75
  • Price/Sales 7.67
  • Price/Cash Flow 22.31
  • Price/Book 4.30

Price Performance

See More
Period Period Low Period High Performance
1-Month
98.22 +4.85%
on 04/06/17
103.82 -0.81%
on 04/24/17
-0.84 (-0.81%)
since 03/24/17
3-Month
95.68 +7.63%
on 02/07/17
108.58 -5.16%
on 03/01/17
+5.03 (+5.14%)
since 01/24/17
52-Week
91.45 +12.61%
on 04/29/16
117.42 -12.30%
on 07/08/16
+8.16 (+8.61%)
since 04/22/16

Most Recent Stories

More News
Bio-Techne To Present At The Deutsche Bank 42nd Annual Health Care Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Deutsche Bank 42nd Annual Health Care conference on Wednesday, May 3,...

TECH : 103.08 (+1.30%)
DB : 18.42 (+11.64%)
4 Sell-Ranked Drug Stocks Investors Should Avoid Ahead of Earnings

Here is a look at four Sell-Ranked drug stocks with negative earnings ESP that should be avoided ahead of earnings.

TECH : 103.08 (+1.30%)
DRNA : 2.95 (+0.34%)
VYGR : 10.38 (+0.39%)
JNJ : 122.74 (+0.80%)
VRX : 8.74 (+2.70%)
Bio-Techne To Host Conference Call On May 2, 2017 To Announce Third Quarter Financial Results

Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on May 2, 2017, at 8:00 a.m. CDT to review third quarter fiscal 2017 financial results.

TECH : 103.08 (+1.30%)
Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for Adult "Ground-state" Stem Cell Technology

Bio-Techne has entered into an exclusive license agreement with Multiclonal Therapeutics (MCT) to commercialize reagents and media systems in the research reagent field intended for cloning, propagating,...

TECH : 103.08 (+1.30%)
Innovative Veterinary Diagnostic Setting A New Standard

Bio-Techne Corporation has partnered with Brazil-based DK Diagnostics to release its first diagnostic tool for the veterinary market. The PARATEST system is an innovative parasitological system which contains...

TECH : 103.08 (+1.30%)
Implied Volatility Surging for Bio-Techne (TECH) Stock Options

Options traders are pricing in a big move for Bio-Techne (TECH) shares as it has huge implied volatility.

TECH : 103.08 (+1.30%)
Bio-Techne Named "Company of the Year" by Instrument Business Outlook

Bio-Techne has been named the 2016 Company of the Year by Instrument Business Outlook (IBO). IBO is the most authoritative newsletter for tracking developments in the analytical and life science instrumentation...

TECH : 103.08 (+1.30%)
Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More

Earnings growth turned positive in the last quarter and things are surely looking up as we stand in the middle of the earnings season.

TECH : 103.08 (+1.30%)
CELG : 123.28 (+0.83%)
USNA : 55.20 (-2.30%)
JNJ : 122.74 (+0.80%)
LLY : 83.03 (+1.39%)
GILD : 66.20 (+0.41%)
ABBV : 64.87 (+1.65%)
MNK : 44.81 (+2.96%)
PFE : 33.83 (+0.56%)
BIIB : 277.39 (+1.63%)
Bio-Techne To Host Conference Call On February 7, 2017 To Announce Second Quarter Financial Results

Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, February 7, 2017, at 8:00 a.m. CST to review second quarter fiscal 2017 financial results.

TECH : 103.08 (+1.30%)
Bio-Techne Congratulates Astute Medical on Clinical Trial Results

In a major study released this weekend from the University Hospital Muenster, Germany1 (http://www.multivu.com/players/English/7899551-nephrocheck-test-acute-kidney-injury-outcomes/), Astute Medical's...

TECH : 103.08 (+1.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Support & Resistance

2nd Resistance Point 103.39
1st Resistance Point 102.58
Last Price 103.08
1st Support Level 101.21
2nd Support Level 100.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.